Skip to Content

SHIRE 465 50 mg (Mydayis 50 mg)

Generic Name: amphetamine/dextroamphetamine

Pill with imprint SHIRE 465 50 mg is Purple / White, Capsule-shape and has been identified as Mydayis 50 mg. It is supplied by Shire US, Inc..

Mydayis is used in the treatment of adhd and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Mydayis 50 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for SHIRE 465 50 mg

Mydayis 50 mg SHIRE 465 50 mg

Mydayis

Generic Name
amphetamine/dextroamphetamine
Imprint
SHIRE 465 50 mg
Strength
50 mg
Color
Purple / White
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Shire US, Inc.
National Drug Code (NDC)
54092-0477
Inactive Ingredients
methacrylic acid - ethyl acrylate copolymer (1:1) type a, sucrose, magnesium silicate, triethyl citrate, D&C Red No. 28, D&C Red No. 33, titanium dioxide, FD&C Blue No. 1

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.